Effects of the uremic toxin indoxyl sulphate on human microvascular endothelial cells.


Journal

Journal of applied toxicology : JAT
ISSN: 1099-1263
Titre abrégé: J Appl Toxicol
Pays: England
ID NLM: 8109495

Informations de publication

Date de publication:
12 2022
Historique:
revised: 14 07 2022
received: 08 06 2022
accepted: 15 07 2022
pubmed: 20 7 2022
medline: 15 11 2022
entrez: 19 7 2022
Statut: ppublish

Résumé

Indoxyl sulphate (IS) is a uremic toxin accumulating in the plasma of chronic kidney disease (CKD) patients. IS accumulation induces side effects in the kidneys, bones and cardiovascular system. Most studies assessed IS effects on cell lines by testing higher concentrations than those measured in CKD patients. Differently, we exposed a human microvascular endothelial cell line (HMEC-1) to the IS concentrations measured in the plasma of healthy subjects (physiological) or CKD patients (pathological). Pathological concentrations reduced cell proliferation rate but did not increase long-term oxidative stress level. Indeed, total protein thiols decreased only after 24 h of exposure in parallel with an increased Nrf-2 protein expression. IS induced actin cytoskeleton rearrangement with formation of stress fibres. Proteomic analysis supported this hypothesis as many deregulated proteins are related to actin filaments organization or involved in the endothelial to mesenchymal transition. Interestingly, two proteins directly linked to cardiovascular diseases (CVD) in in vitro and in vivo studies underwent deregulation: COP9 signalosome complex subunit 9 and thrombomodulin. Future experiments will be needed to investigate the role of these proteins and the signalling pathways in which they are involved to clarify the possible link between CKD and CVD.

Identifiants

pubmed: 35854198
doi: 10.1002/jat.4366
pmc: PMC9796800
doi:

Substances chimiques

Indican N187WK1Y1J
Uremic Toxins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1948-1961

Subventions

Organisme : Università degli Studi di Milano

Informations de copyright

© 2022 The Authors. Journal of Applied Toxicology published by John Wiley & Sons Ltd.

Références

Nat Rev Gastroenterol Hepatol. 2010 May;7(5):281-7
pubmed: 20368740
BMC Nephrol. 2013 Mar 04;14:56
pubmed: 23496811
Kidney Int Suppl. 2009 Dec;(114):S12-9
pubmed: 19946322
FASEB J. 2012 Aug;26(8):3440-52
pubmed: 22593542
IUBMB Life. 2001 Jul;52(1-2):55-9
pubmed: 11795594
Circ Res. 2012 Nov 9;111(11):1470-83
pubmed: 23139286
Clin Chim Acta. 2018 Sep;484:197-206
pubmed: 29864403
Free Radic Biol Med. 2009 Sep 15;47(6):675-83
pubmed: 19527783
J Biochem. 1996 Apr;119(4):791-8
pubmed: 8743583
J Recept Signal Transduct Res. 2005;25(1):19-33
pubmed: 15960392
PLoS One. 2016 Jan 22;11(1):e0147159
pubmed: 26799394
BMC Pharmacol Toxicol. 2018 Sep 03;19(1):53
pubmed: 30176914
Nephron. 1996;74(2):349-55
pubmed: 8893154
J Am Soc Nephrol. 2014 Sep;25(9):1897-907
pubmed: 24812165
J Ren Nutr. 2014 Sep;24(5):286-91
pubmed: 24480117
Toxins (Basel). 2016 Nov 30;8(12):
pubmed: 27916890
Kidney Int. 2003 May;63(5):1934-43
pubmed: 12675874
J Thromb Haemost. 2003 Jul;1(7):1515-24
pubmed: 12871287
Nephrol Dial Transplant. 2013 Jan;28(1):70-8
pubmed: 22610984
Curr Top Cell Regul. 2000;36:151-80
pubmed: 10842751
Toxins (Basel). 2014 Feb 20;6(2):665-78
pubmed: 24561478
Kidney Int. 2004 Feb;65(2):442-51
pubmed: 14717914
Bone. 2013 Dec;57(2):477-83
pubmed: 23920356
Blood. 2018 Jul 12;132(2):148-158
pubmed: 29866818
Nephron Exp Nephrol. 2014;128(1-2):1-8
pubmed: 25376195
J Ren Nutr. 2015 Mar;25(2):155-9
pubmed: 25511523
Free Radic Biol Med. 2015 Dec;89:443-51
pubmed: 26453922
Biomolecules. 2019 Jun 05;9(6):
pubmed: 31195722
J Appl Toxicol. 2022 Dec;42(12):1948-1961
pubmed: 35854198
Circ J. 2013;77(1):224-30
pubmed: 23037589
Ther Apher Dial. 2011 Apr;15(2):125-8
pubmed: 21426501
Oncol Res. 2017 Jan 2;25(1):99-105
pubmed: 28081738
J Cell Biol. 1996 Dec;135(5):1309-21
pubmed: 8947553
J Thromb Haemost. 2007 Jun;5(6):1302-8
pubmed: 17403109
Clin Chem. 2006 Apr;52(4):601-23
pubmed: 16484333
Methods Mol Med. 2005;110:39-48
pubmed: 15901925
Bio Protoc. 2016 Nov 5;6(21):
pubmed: 28573164
PLoS One. 2018 Feb 23;13(2):e0193342
pubmed: 29474405
Trends Cell Biol. 2010 Aug;20(8):470-81
pubmed: 20688255
Toxicol Lett. 2015 Apr 16;234(2):110-9
pubmed: 25703824
Biochem Cell Biol. 2011 Apr;89(2):115-29
pubmed: 21455264
Kidney Int. 2013 Feb;83(2):308-15
pubmed: 22992469
Lancet. 2017 Mar 25;389(10075):1238-1252
pubmed: 27887750
Annu Rev Pharmacol Toxicol. 2013;53:401-26
pubmed: 23294312
Nefrologia. 2017 Jan - Feb;37(1):9-19
pubmed: 27553986
J Am Soc Nephrol. 2004 Aug;15(8):1983-92
pubmed: 15284284
Kidney Int. 2007 Apr;71(8):738-43
pubmed: 17264878
Biochem J. 2008 May 1;411(3):581-91
pubmed: 18215130
Am J Cardiovasc Dis. 2015 Mar 20;5(1):33-52
pubmed: 26064791
Biosci Rep. 2019 Aug 2;39(8):
pubmed: 30482882
J Am Soc Nephrol. 2013 Dec;24(12):1981-94
pubmed: 24009240
Am J Pathol. 2001 Sep;159(3):797-802
pubmed: 11549570
Am J Kidney Dis. 2008 Apr;51(4):603-12
pubmed: 18371536
J Cell Biochem. 2012 Mar;113(3):1034-43
pubmed: 22213462
Oncogene. 2019 Sep;38(39):6567-6584
pubmed: 31406248
J Lab Clin Med. 1994 Jul;124(1):96-104
pubmed: 8035108
Thromb Haemost. 2002 Feb;87(2):211-7
pubmed: 11858479
J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12
pubmed: 2359136
Clin J Am Soc Nephrol. 2008 Mar;3(2):505-21
pubmed: 18184879
J Am Soc Nephrol. 2014 Apr;25(4):657-70
pubmed: 24231662
Thromb Haemost. 2000 Mar;83(3):462-8
pubmed: 10744154
Life Sci. 2017 Sep 15;185:23-29
pubmed: 28754616
Clin J Am Soc Nephrol. 2011 Jan;6(1):30-9
pubmed: 20876676
Lancet. 2013 Jul 20;382(9888):260-72
pubmed: 23727169
Nat Protoc. 2006;1(3):1112-6
pubmed: 17406391
Anal Biochem. 2014 Dec 15;467:1-3
pubmed: 25193447
Circ J. 2010 Oct;74(10):2216-24
pubmed: 20818133
Dev Dyn. 2018 Mar;247(3):492-508
pubmed: 28891150
Ann Biomed Eng. 2002 Apr;30(4):430-46
pubmed: 12085996
Pol J Pharmacol. 2002 May-Jun;54(3):215-23
pubmed: 12398152
Diabetologia. 2014 Feb;57(2):424-34
pubmed: 24317792

Auteurs

Graziano Colombo (G)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, Milan, Italy.

Emanuela Astori (E)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, Milan, Italy.

Lucia Landoni (L)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, Milan, Italy.

Maria L Garavaglia (ML)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, Milan, Italy.

Alessandra Altomare (A)

Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.

Maria C Lionetti (MC)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, Milan, Italy.

Nicoletta Gagliano (N)

Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.

Daniela Giustarini (D)

Department of Life Sciences, Laboratory of Pharmacology and Toxicology, University of Siena, Siena, Italy.

Ranieri Rossi (R)

Department of Life Sciences, Laboratory of Pharmacology and Toxicology, University of Siena, Siena, Italy.

Aldo Milzani (A)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, Milan, Italy.

Isabella Dalle-Donne (I)

Department of Biosciences (Department of Excellence 2018-2022), Università degli Studi di Milano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH